4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-18-031589
SVP & Chief Scientific Officer sold 3,435 shares at $83.39 ($286,445)
From the SEC's structured data for this filing
Trades in this filing
Doberstein Stephen K · SVP & Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-05-16 | Sale : show line 1 in the form | −3,435 | $83.39 | $286,445 | 63,959 | D |
| Open-market sales · 3,435 sh · avg $83.39 · $286,445 | ||||||
Loading xslF345X03/doc4.xml…